Skip Navigation
National Cancer Institute

Director's Page

Julia Rowland

Julia Rowland, PhD
Director, Office of Cancer Survivorship

Dr. Rowland received her PhD in Developmental Psychology from Columbia University and completed a two-year NIH-funded post-doctoral fellowship at Memorial Sloan-Kettering Cancer Center in psychosocial oncology. While at MSKCC, where she held joint appointments in pediatrics and neurology, Dr. Rowland helped to develop and was the first Director of the Post-Treatment Resource Program, an innovative resource that continues to provide a full range of non-medical services to patients and their families after the end of treatment. In 1990 Dr. Rowland became founding Director of the Psycho-Oncology Program at Georgetown University, where she held appointments in the Department of Psychiatry and at the Lombardi Cancer Center. Since joining the NCI in 1999, she has sought to champion the visibility of and investment in cancer survivorship research both within the Institute and across other federal and non-governmental agencies, and to raise public awareness about the health and quality-of-life needs of the growing population of cancer survivors and their families.

Across her career as a clinician, researcher and teacher in the area of psychosocial aspects of cancer, Dr. Rowland has worked with and conducted competitively funded research among both pediatric and adult cancer survivors and their families, and published broadly in psycho-oncology. She co-edited the ground-breaking text Handbook of Psychooncology (Oxford University Press, 1989), as well as the more recent Handbook of Cancer Control and Behavioral Science (American Psychological Association Press, 2008). Her particular areas of research interest are in developmental stage and adaptation to illness, sexual function post-treatment, the interface between cancer and aging, cancer caregiving and its impact on the health and well-being of providers and recipients of this care, health promotion and adherence to medical recommendations after cancer, and the development and application of metrics to evaluate the impact of cancer survivorship research on the quality of care and outcomes for the growing population of those living long-term with a cancer history.